The Commission is tasked with making recommendations for improving the Federal response to opioid misuse and abuse.
Best evidence informs us that medical marijuana access is associated with reduced levels of opioid-related abuse, hospitalization, and mortality. Nonetheless, this administration continues to express skepticism with regard to the safety and efficacy of medical marijuana.
Today in The Hill newspaper, NORML Deputy Director Paul Armentano writes:
It is crucial that our government hear from us. Click here to send a message to the Commission urging them to include medical marijuana as part of any national response to the opioid crisis.
Read the rest of this article here … (we didn’t write it)